Clinical Trials Browser

Interventional × iso-sulfan blue × 90 days × Clear all

NCT03927027 2026-04-21

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

Phase 3 Active not recruiting

Breast Neoplasms

NCT07518485 2026-04-08

preReDSeL

Phase 2 Not yet recruiting

Mouth Neoplasms